Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
The vaccine regimen tested in the Imbokodo trial was similar to the J&J COVID-19 vaccine, but an mRNA approach may hold more promise.
African Americans with multiple sclerosis face faster disease progression and poorer outcomes compared with their white peers.
Why Black people are at greater risk for this dementia than their white peers.
Right now, it typically takes six years after an HIV drug is approved to obtain data for pregnant people.
Health equity advocate Karen Winkfield, MD, MPH, works to enroll more underserved people with cancer in lifesaving clinical trials.
Certain racial/ethnic groups and older people aren’t being adequately represented and trial reporting guidelines aren’t being followed.
Deen wants other people with RA, especially people of color, to know about getting involved with research and patient advocacy.
Eventual vaccination of children will be crucial to subduing the COVID virus, but pediatricians are split on how fast to move toward that.
The Senate-passed bill memorializing Henrietta Lacks aims to address underrepresentation in cancer clinical trials.
Keesha Sharp joins Jaime Camil, Cedric the Entertainer and Michael Ealy to push for diversity in cancer trials.
The vaccine demonstrated 95% efficacy in an ongoing Phase III trial.
The front-runner coronavirus vaccine appears to protect people from symptomatic disease.
Some experts want to hold out for a more optimal vaccine. Others believe accepting the best possible vaccine sooner than later is ideal.
A checkpoint inhibitor combination and an antibody-drug conjugate may offer new treatment options.
Jamil Rivers, 42, is the board president of METAvivor, a nonprofit breast cancer organization. She is living with metastatic breast cancer.
None of the four drugs tested in the WHO’s Solidarity trial reduced mortality or duration of hospitalization.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.